IMpact of pneumococcal conjugate vaccine in reducing overall exacerbation rate in COPD: results of the IMPROVE COPD study
Abstract Background Exacerbations triggered by infectious agents punctuate the course of COPD subjects and have a bearing on clinical outcomes. Pneumococcal vaccination brings down the occurrence of community-acquired pneumonia in COPD patients. The impact on exacerbation rate, although deemed to be...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SpringerOpen
2025-03-01
|
| Edice: | The Egyptian Journal of Bronchology |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s43168-025-00381-7 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
